Immuno-Oncology Educational Series

Oslo Cancer Cluster, Bristol-Meyers Squibb and MSD continues to deliver the much appreciated immuno-oncology educational series in 2016. The first meeting in Oslo features international key note Professor Petri Bono from Helsinki University Hospital.

As this is an educational seminar for clinicians we to limit the number of company representative to one per company.

We will also live stream the meeting.

• Please register below – few seats available
  If you are a clinician and would like to join and the registration is closed – please write an e-mail to Nadine Lohs on nadine@oslocancercluster.no
• PROGRAM may be downloaded

PROGRAM

Chairperson Prof. Steinar Aamdal, Head, Section for Clinical Cancer Research, Oslo University Hospital

14:30–15:00 Registration and coffee

15:00–15:10 Welcome and introduction – Prof. Steinar Aamdal, Oslo University Hospital

15:10–15:50 Development of I-O therapies for the treatment of renal and other solid tumors

– Prof. Petri Bono, Clinical Trial Unit, Helsinki University Hospital, Finland

15:50–16:10 Discussion

16:10–16:30 The immunologists’ perspective: The dynamics of immunological signatures during cancer treatment

– Alexandre Corthay; Head of Tumor immunology group; Department of Pathology, Oslo University Hospital, President of the Norwegian Society for Immunology

16:30 – 16:50 The molecular pathologists’ perspective: Immunological fingerprint in breast cancer patients – what does that mean?

– Hege G. Russnes, Dept. of Genetics, Institute for Cancer Research, and Dept. of Pathology, Oslo University Hospital

16:50–17:00 Wrap-up and Closing

17:00–18:00 Networking session with light refreshments

We look forward to a stimulating seminar!

Oslo Cancer Cluster’s members BMS and MSD kindly support this Educational Series.

For any questions, please contact jh@oslocancercluster.no and eka@oslocancercluster.no